Compass Therapeutics: Key Upcoming September Investor Engagements
Engagements on the Horizon for Compass Therapeutics
BOSTON – Compass Therapeutics, Inc. (“Compass”) (Nasdaq: CMPX), a clinical-stage biopharmaceutical company with a strong focus on oncology, is gearing up for a significant month ahead. The firm has planned various investor events in September aimed at showcasing its groundbreaking antibody-based therapies designed to treat a wide range of human diseases.
Details of Upcoming Investor Events
Compass Therapeutics will actively participate in several high-profile conferences throughout September. Each event serves as a vital platform enabling investors to gain insights into their innovative product pipeline and strategic direction.
Citi’s 2025 Biopharma Back to School Conference
This esteemed conference will feature Compass, located in Boston, as part of its programming. The event is a fantastic opportunity for investors and industry professionals to connect and discuss advancements in biopharmaceuticals.
Cantor Global Healthcare Conference
Set in the vibrant atmosphere of New York, this conference will occur early in the month. Scheduled for September 3, it features Compass Therapeutics at 2:10 PM ET. Attendees can expect a detailed presentation on the latest developments within the company’s therapeutic offerings. A webcast will also be available, allowing a wider audience to tune in and receive the latest updates.
H.C. Wainwright 27th Annual Global Investment Conference
On September 8, 2025, Compass will present at this notable conference, taking place in New York at 11 AM ET. This event focuses on providing insights from leading institutions in the healthcare sector, and Compass is expected to highlight its strategic advancements and outlook at this pivotal time.
Morgan Stanley 23rd Annual Global Healthcare Conference
This conference, slated for September 9 at 5:35 PM ET, represents the culmination of Compass’s September events. As experts from various fields converge to discuss groundbreaking healthcare advancements, Compass will be on hand to share its vision and progress.
Replay and Availability of Presentations
Investors who are unable to attend the live presentations need not worry. Compass Therapeutics will archive the conference proceedings for 90 days after each event on their dedicated Events page. This ensures that all interested parties have ample opportunity to access the valuable information shared during these conferences.
Your Guide to Compass Therapeutics
Founded in 2014 and headquartered in Boston, Compass Therapeutics is dedicated to revolutionizing cancer treatments through the development of proprietary antibody-based therapeutics. The company's primary focus lies in understanding the intricate relationships between angiogenesis, immune response, and tumor growth. It boasts a rich pipeline of innovative product candidates tailored to engage multiple biological pathways crucial for an effective anti-tumor response.
With a clear strategic direction, Compass is advancing its therapies through clinical development, exploring both standalone and combination approaches grounded in robust clinical data. Their commitment to addressing some of the toughest challenges in oncology underscores their long-term vision for growth within the biopharmaceutical landscape.
Stay Connected with Compass Therapeutics
If you’re an investor or stakeholder interested in learning more about Compass Therapeutics, direct inquiries can be made via email. Investor relations can be reached at ir@compasstherapeutics.com. For media inquiries, reach out to Anna Gifford, Chief of Staff, at media@compasstherapeutics.com or by phone at 617-500-8099.
Frequently Asked Questions
What presentations will Compass Therapeutics hold during September?
Compass will present at Citi’s 2025 Biopharma Back to School Conference, Cantor Global Healthcare Conference, H.C. Wainwright Global Investment Conference, and Morgan Stanley Healthcare Conference.
How can I access the presentations if I miss them live?
All presentations will be archived for 90 days on Compass’s Events page for later viewing.
What is the mission of Compass Therapeutics?
Compass is committed to developing innovative antibody-based therapies to treat cancer and advance the field of oncology.
When was Compass Therapeutics founded?
Compass Therapeutics was founded in 2014 and is based in Boston.
Where can I find more information about Compass Therapeutics?
Investors can visit the company's website or contact their investor relations department via email for more details.
About The Author
Contact Ryan Hughes privately here. Or send an email with ATTN: Ryan Hughes as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.